Rippling muscle disease

Journal of Clinical Neuroscience

Volumn 13, Issue 5, 2006, Pages 576-578

  Roberts, Helene L ^a   Day, Bruce ^a   Lo, Harriet ^b   McLean, Catriona ^a   North, Kathryn ^b  

^a MONASH UNIVERSITY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Caveolin 3 deficiency; Caveolinopathies; Rippling muscle disease

Indexed keywords

CAVEOLIN 3; NONSTEROID ANTIINFLAMMATORY AGENT; QUININE SULFATE; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MUSCLE CRAMP; MUSCLE HYPERTROPHY; MUSCLE STIFFNESS; MYALGIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RIPPLING MUSCLE DISEASE;

CAVEOLIN 3; FEMALE; HUMANS; MIDDLE AGED; MUSCLE RIGIDITY; MUSCULAR DISEASES; POINT MUTATION;

EID: 33744940868     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.06.015     Document Type: Article

References (15)

1. Torbergsen T. Rippling muscle disease: a review. Muscle Nerve Suppl. 11 (2002) S103-S107
2. Nishino I., and Ozawa E. Muscular dystrophies. Curr Opin Neurol 15 (2002) 539-544
3. Minetti C., Sotgia F., Bruno C., et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18 (1998) 365-368
4. Woodman S.E., Sotgia F., Galbiati F., Minetti C., and Lisanti M.P. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 62 (2004) 538-543
5. Cooper S.T., Lo H.P., and North K.N. Single section Western blot: improving the molecular diagnosis of the muscular dystrophies. Neurology 61 (2003) 93-97
6. Ricker K., Moxley R.T., and Rohkamm R. Rippling muscle disease. Arch Neurol 46 (1989) 405-408
7. Vorgerd M., Bolz H., Patzold T., Kubisch C., Malin J.P., and Mortier W. Phenotypic variability in rippling muscle disease. Neurology 52 (1999) 1453-1459
8. Betz R.C., Schoser B.G., Kasper D., et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28 (2001) 218-219
9. Schara U., Vorgerd M., Popovic N., Schoser B.G., Ricker K., and Mortier W. Rippling muscle disease in childhood. J Child Neurol 17 (2002) 483-490
10. Tateyama M., Aoki M., Nishino I., et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 58 (2002) 323-325
11. Vorgerd M., Ricker K., Ziemssen F., et al. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 57 (2001) 2273-2277
12. Yabe I., Kawashima A., Kikuchi S., et al. Caveolin-3 gene mutation in Japanese with rippling muscle disease. Acta Neurol Scand 108 (2003) 47-51
13. Figarella-Branger D., Pouget J., Bernard R., et al. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene. Neurology 61 (2003) 562-564
14. Carbone I., Bruno C., Sotgia F., et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 54 (2000) 1373-1376
15. Mion C.C., Tsanaclis A.M., Lusvarghi E., Brotto M.W., and Levy J.A. Increased muscular irritability syndrome: treatment with nifedipine. Report of a case. Arq Neuropsiquiatr 42 (1984) 72-76